...
首页> 外文期刊>International journal of paediatric dentistry >Comparison of zinc oxide and eugenol, and Vitapex for root canal treatment of necrotic primary teeth.
【24h】

Comparison of zinc oxide and eugenol, and Vitapex for root canal treatment of necrotic primary teeth.

机译:氧化锌,丁香酚和Vitapex在根管治疗坏死乳牙方面的比较。

获取原文
获取原文并翻译 | 示例
           

摘要

Summary. Objectives. The aims of this study were to evaluate iodoform base materials for root canal treatment of necrotic primary teeth, and to compare them with traditionally used zinc oxide and eugenol (ZOE). Sample and Methods. Zinc oxide and eugenol and Vitapex (a premixed calcium hydroxide and iodoform paste) were compared for root canal treatment in 52 necrotic primary teeth in two groups of children with a mean age of 5 years and 8.4 months. All the patients were followed-up clinically and radiographically 3 months and 10-16 months postoperatively. Results. The overall success rates of Vitapex and ZOE were 100% and 78.5%, respectively. Using Fisher's Exact Test, the difference was statistically significant (P < 0.05). Conclusion. Both ZOE and Vitapex gave encouraging results. Vitapex, however, can be used more safely whenever there is a doubt about the patient's return for follow-up.
机译:概要。目标。这项研究的目的是评估碘仿基础材料用于根管治疗坏死的乳牙,并将其与传统使用的氧化锌和丁香酚(ZOE)进行比较。样品和方法。比较了两组平均年龄分别为5岁和8.4个月的儿童中52颗坏死的乳牙中的氧化锌,丁香酚和Vitapex(预混合的氢氧化钙和碘仿糊剂)进行的根管治疗。所有患者均在术后3个月和10-16个月接受临床和影像学随访。结果。 Vitapex和ZOE的总体成功率分别为100%和78.5%。使用Fisher精确检验,差异具有统计学意义(P <0.05)。结论。 ZOE和Vitapex均给出了令人鼓舞的结果。但是,如果对患者的返回有疑问,可以更安全地使用Vitapex。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号